Implication and Regulation of AMPK during Physiological and Pathological Myeloid Differentiation

por Jacquel, Arnaud, Luciano, Frederic, Robert, Guillaume, Auberger, Patrick
Publicado 2018

Mechanisms of AXL overexpression and function in Imatinib-resistant chronic myeloid leukemia cells

por Dufies, Maeva, Jacquel, Arnaud, Belhacene, Nathalie, Robert, Guillaume, Cluzeau, Thomas, Luciano, Fréderic, Cassuto, Jill Patrice, Raynaud, Sophie, Auberger, Patrick
Publicado 2011

The small heat shock protein B8 (HSPB8) confers resistance to bortezomib by promoting autophagic removal of misfolded proteins in multiple myeloma cells

por Hamouda, Mohamed-Amine, Belhacene, Nathalie, Puissant, Alexandre, Colosetti, Pascal, Robert, Guillaume, Jacquel, Arnaud, Mari, Bernard, Auberger, Patrick, Luciano, Frederic
Publicado 2014

Phenotypic and genotypic characterization of azacitidine-sensitive and resistant SKM1 myeloid cell lines

por Cluzeau, Thomas, Dubois, Alix, Jacquel, Arnaud, Luciano, Frederic, Renneville, Aline, Preudhomme, Claude, Karsenti, Jean Michel, Mounier, Nicolas, Rohrlich, Pierre, Raynaud, Sophie, Mari, Bernard, Robert, Guillaume, Auberger, Patrick
Publicado 2014

BCL2L10 is a predictive factor for resistance to Azacitidine in MDS and AML patients

por Cluzeau, Thomas, Robert, Guillaume, Mounier, Nicolas, Karsenti, Jean Michel, Dufies, Maeva, Puissant, Alexandre, Jacquel, Arnaud, Renneville, Aline, Preudhomme, Claude, Cassuto, Jill-Patrice, Raynaud, Sophie, Luciano, Frederic, Auberger, Patrick
Publicado 2012

All tyrosine kinase inhibitor-resistant chronic myelogenous cells are highly sensitive to Ponatinib

por Cassuto, Ophélie, Dufies, Maeva, Jacquel, Arnaud, Robert, Guillaume, Ginet, Clémence, Dubois, Alix, Hamouda, Amine, Puissant, Alexandre, Luciano, Fredéric, Karsenti, Jean-Michel, Legros, Laurence, Cassuto, Jill Patrice, Lenain, Pascal, Auberger, Patrick
Publicado 2012

The Polo-like kinase 1 inhibitor onvansertib represents a relevant treatment for head and neck squamous cell carcinoma resistant to cisplatin and radiotherapy

por Hagege, Anais, Ambrosetti, Damien, Boyer, Julien, Bozec, Alexandre, Doyen, Jérôme, Chamorey, Emmanuel, He, Xingkang, Bourget, Isabelle, Rousset, Julie, Saada, Esma, Rastoin, Olivia, Parola, Julien, Luciano, Frederic, Cao, Yihai, Pagès, Gilles, Dufies, Maeva
Publicado 2021

Differentiation inducing factor 3 mediates its anti-leukemic effect through ROS-dependent DRP1-mediated mitochondrial fission and induction of caspase-independent cell death

por Dubois, Alix, Ginet, Clemence, Furstoss, Nathan, Belaid, Amine, Hamouda, Mohamed Amine, El Manaa, Wedjene, Cluzeau, Thomas, Marchetti, Sandrine, Ricci, Jean Ehrland, Jacquel, Arnaud, Luciano, Frederic, Driowya, Mohsine, Benhida, Rachid, Auberger, Patrick, Robert, Guillaume
Publicado 2016

Targeting of c-MET and AXL by cabozantinib is a potential therapeutic strategy for patients with head and neck cell carcinoma

por Hagege, Anais, Saada-Bouzid, Esma, Ambrosetti, Damien, Rastoin, Olivia, Boyer, Julien, He, Xingkang, Rousset, Julie, Montemagno, Christopher, Doyen, Jérome, Pedeutour, Florence, Parola, Julien, Bourget, Isabelle, Luciano, Frederic, Bozec, Alexandre, Cao, Yihai, Pagès, Gilles, Dufies, Maeva
Publicado 2022

ATP-competitive Plk1 inhibitors induce caspase 3-mediated Plk1 cleavage and activation in hematopoietic cell lines

por Dufies, Maeva, Ambrosetti, Damien, Boulakirba, Sonia, Calleja, Anne, Savy, Coline, Furstoss, Nathan, Zerhouni, Marwa, Parola, Julien, Aira-Diaz, Lazaro, Marchetti, Sandrine, Orange, Francois, Lacas-Gervais, Sandra, Luciano, Frederic, Jacquel, Arnaud, Robert, Guillaume, Pagès, Gilles, Auberger, Patrick
Publicado 2017

IL-34 and CSF-1 display an equivalent macrophage differentiation ability but a different polarization potential

por Boulakirba, Sonia, Pfeifer, Anja, Mhaidly, Rana, Obba, Sandrine, Goulard, Michael, Schmitt, Thomas, Chaintreuil, Paul, Calleja, Anne, Furstoss, Nathan, Orange, François, Lacas-Gervais, Sandra, Boyer, Laurent, Marchetti, Sandrine, Verhoeyen, Els, Luciano, Frederic, Robert, Guillaume, Auberger, Patrick, Jacquel, Arnaud
Publicado 2018

Retraction Note: LAMP2 expression dictates azacytidine response and prognosis in MDS/AML

por Dubois, Alix, Furstoss, Nathan, Calleja, Anne, Zerhouni, Marwa, Cluzeau, Thomas, Savy, Coline, Marchetti, Sandrine, Hamouda, Mohamed Amine, Boulakirba, Sonia, Orange, François, Lacas-Gervais, Sandra, Karsenti, Jean-Michel, Mounier, Nicolas, Tamburini, Jérôme, Puissant, Alexandre, Luciano, Frederic, Jacquel, Arnaud, Auberger, Patrick, Robert, Guillaume
Publicado 2020

BCL2L10 positive cells in bone marrow are an independent prognostic factor of azacitidine outcome in myelodysplastic syndrome and acute myeloid leukemia

por Vidal, Valérie, Robert, Guillaume, Goursaud, Laure, Durand, Laetitia, Ginet, Clemence, Karsenti, Jean Michel, Luciano, Frederic, Gastaud, Lauris, Garnier, Georges, Braun, Thorsten, Hirsch, Pierre, Raffoux, Emmanuel, Nloga, Anne Marie, Padua, Rose Ann, Dombret, Hervé, Rohrlich, Pierre, Ades, Lionel, Chomienne, Christine, Auberger, Patrick, Fenaux, Pierre, Cluzeau, Thomas
Publicado 2017

BCL-B (BCL2L10) is overexpressed in patients suffering from multiple myeloma (MM) and drives an MM-like disease in transgenic mice

por Hamouda, Mohamed-Amine, Jacquel, Arnaud, Robert, Guillaume, Puissant, Alexandre, Richez, Valentine, Cassel, Romeo, Fenouille, Nina, Roulland, Sandrine, Gilleron, Jerome, Griessinger, Emmanuel, Dubois, Alix, Bailly-Maitre, Beatrice, Goncalves, Diogo, Mallavialle, Aude, Colosetti, Pascal, Marchetti, Sandrine, Amiot, Martine, Gomez-Bougie, Patricia, Rochet, Nathalie, Deckert, Marcel, Avet-Loiseau, Herve, Hofman, Paul, Karsenti, Jean-Michel, Jeandel, Pierre-Yves, Blin-Wakkach, Claudine, Nadel, Bertrand, Cluzeau, Thomas, Anderson, Kenneth C., Fuzibet, Jean-Gabriel, Auberger, Patrick, Luciano, Frederic
Publicado 2016